true,restored,edge_type
"['10.1002/cbdv.200800342', 'Cytotoxic']","['10.1002/cbdv.200800342', ['Cytotoxic activity against human leukemia (MOLT-4), melanoma (MDA-MB-435), colon (HCT-8), and glyoblastoma (SF-295) cancer cell lines, and against L-929 (normal fibroblasts).', 'Cytotoxic activity against human tumor cell lines.', 'Cytotoxic activity against human tumor cell lines.', 'Cytotoxic activity against human tumor cell lines.', 'Cytotoxic activity against human tumor cell lines.', 'Strongest cytotoxicity against all tumor cell lines tested, compared to normal L-929 cells. Comparable with the positive control doxorubicin.', 'No cytotoxic activity to cancer cells, indicating that the presence of these CO groups at C(18) and C(19) is incompatible with the cytotoxic activity. Derived from degradation of casearin X in CDCl3.']]",doi_bioActivity
"['10.1016/0031-9422(91)85077-D', 'Antifungal']","['10.1016/0031-9422(91)85077-D', ['Inhibited the growth of Aspergillus niger, Cladosporium cladosporioides, and Colletotrichum gloeosporioides; fungitoxic properties']]",doi_bioActivity
"['10.1016/0040-4020(95)00254-6', 'Cytotoxic']","['10.1016/0040-4020(95)00254-6', ['Active in a mechanism-based DNA-modifying yeast assay and cytotoxic in Vero monkey and Chinese hamster ovary cell assays', 'Moderately active in Vero monkey and Chinese hamster ovary cell cytotoxicity assays', 'Unknown specific bioactivity from the provided data', 'Assumed bioactive but no specific bioactivity profile provided', 'Assumed bioactive but no specific bioactivity profile provided', 'Unknown specific bioactivity from the provided data', 'Assumed bioactive but no specific bioactivity profile provided']]",doi_bioActivity
"['10.1016/S0031-9422(00)00477-5', 'Antioxidant']","['10.1016/S0031-9422(00)00477-5', ['antioxidant activity', 'antioxidant activity', 'inhibiting the bleaching of β-carotene', 'antioxidant activity', 'inhibiting the bleaching of β-carotene', 'inhibiting the bleaching of β-carotene']]",doi_bioActivity
"['10.1016/S0031-9422(03)00153-5', 'Antitrypanosomal']","['10.1016/S0031-9422(03)00153-5', ['In vitro activity against trypomastigote forms of Trypanosoma cruzi with IC50 value of 59.0 mg/mL', 'In vitro activity against trypomastigote forms of Trypanosoma cruzi with IC50 value of 90.2 mg/mL', 'In vitro activity against trypomastigote forms of Trypanosoma cruzi']]",doi_bioActivity
"['10.1016/S0031-9422(98)00069-7', 'Inhibition of Glycosidase']","['10.1016/S0031-9422(98)00069-7', []]",doi_bioActivity
"['10.1016/j.bmc.2010.12.056', 'Inhibition of Cathepsin V']","['10.1016/j.bmc.2010.12.056', ['Moderate inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 2.5 ± 0.2 µM, Ki value of 0.5 µM', 'Potent and reversible inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 3.9 ± 0.9 µM, Ki value of 1.2 µM', 'Inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 2.2 ± 0.2 µM, Ki value of 1.1 µM', 'Inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 25 ± 5 µM, Ki value of 10.0 µM', 'Moderate inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 10 ± 1 µM, Ki value of 4.2 µM', 'Potent inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 2.2 ± 0.6 µM, Ki value of 1.0 µM', 'Most potent inhibitor in series of cathepsin V with competitive inhibition mechanism, IC50 value of 1.2 ± 0.1 µM, Ki value of 0.2 µM', 'Inhibitor of cathepsin V, IC50 value of 48 ± 5 µM', 'Inhibitor of cathepsin V, IC50 value of 44 ± 3 µM', 'Potent inhibitor of cathepsin V with competitive mechanism, IC50 value of 5.2 ± 0.2 µM, Ki value of 4.4 µM', 'Potent inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 2.8 ± 0.7 µM, Ki value of 1.7 µM']]",doi_bioActivity
"['10.1016/j.bse.2006.06.007', 'Antifungal']","['10.1016/j.bse.2006.06.007', ['Antifungal; Comparable activity to nystatin against C. cladosporioides and C. sphaerospermum', 'Antifungal; Comparable activity to nystatin against C. cladosporioides and C. sphaerospermum']]",doi_bioActivity
"['10.1016/j.jfca.2003.09.013', 'Antioxidant']","['10.1016/j.jfca.2003.09.013', ['Antioxidant; free radical scavenging activity', 'Antioxidant; free radical scavenging activity', 'Antioxidant; free radical scavenging activity', 'Antioxidant; free radical scavenging activity', 'Antioxidant; free radical scavenging activity', 'Antioxidant']]",doi_bioActivity
"['10.1016/j.phytochem.2005.04.043', 'Antifungal']","['10.1016/j.phytochem.2005.04.043', ['Weak in vitro antifungal activity against Cladosporium sphaerospermum and Cladosporioides.', 'Weak in vitro antifungal activity against Cladosporium sphaerospermum and Cladosporioides, induces cell proliferation: 70% on HeLa cells and 25% on CHO cells.', 'Not described.', 'No antifungal activity noted.']]",doi_bioActivity
"['10.1016/j.phytochem.2005.06.019', 'Antioxidant']","['10.1016/j.phytochem.2005.06.019', ['Inactive in DPPH free radical scavenging activity', 'Weak free radical scavenging activity towards DPPH', 'Strong antioxidant activity, comparable with that of caffeic acid', 'Strong antioxidant activity, comparable with that of caffeic acid', 'Weak free radical scavenging activities towards DPPH']]",doi_bioActivity
"['10.1016/j.phytochem.2007.08.012', 'Antitrypanosomal']","['10.1016/j.phytochem.2007.08.012', ['potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y', 'potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y', 'potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y', 'most potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y among the isolated lignans', 'potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y']]",doi_bioActivity
"['10.1021/cc100076k', 'Antitrypanosomal']","['10.1021/cc100076k', ['Inhibition of cathepsin V', 'Inhibition of cathepsin V', 'Inhibition of cathepsin V', 'Inhibition of cathepsin V']]",doi_bioActivity
"['10.1021/cc100076k', 'Inhibition of Cathepsin V']","['10.1021/cc100076k', ['Inhibition of cathepsin V', 'Inhibition of cathepsin V', 'Inhibition of cathepsin V', 'Inhibition of cathepsin V']]",doi_bioActivity
"['10.1021/jf100233y', 'Antioxidant']","['10.1021/jf100233y', ['Antioxidant, Antibacterial, Anti-inflammatory, Antimutagenic, Chemopreventive properties', 'More effective than gallic acid at inhibiting oral bacterial growth and the formation of Streptococcus mutans biofilms', 'Inhibition of cell adhesion, alteration of cell redox status by depletion of both glutathione (GSH) and ATP', 'More efficient than gallic acid as an inhibitor of the enzyme xanthine oxidase, endogenous source of superoxide anion, and of mitochondrial lipid peroxidation induced by FeIII-NADPH', 'Generates radicals that induce oxidative stress and hemolysis']]",doi_bioActivity
"['10.1021/jf60217a066', 'Insect antennae response']","['10.1021/jf60217a066', ['Anesthetic properties, flavor similar to anise seed oil', 'Potent anesthetic, likely responsible for the pharmacological activity of plant infusions']]",doi_bioActivity
"['10.1021/np0103970', 'Antitrypanosomal']","['10.1021/np0103970', ['Weak inhibitory activity against trypomastigote forms of Trypanosoma cruzi', 'Weak inhibitory activity against trypomastigote forms of Trypanosoma cruzi', 'Inactive in brine shrimp lethality test', 'Inactive in brine shrimp lethality test', 'Inactive in brine shrimp lethality test']]",doi_bioActivity
"['10.1021/np030100t', 'Antioxidant']","['10.1021/np030100t', ['Moderate free radical scavenging activity against DPPH as well as antioxidant activity evidenced by redox properties', 'Free radical scavenging activity, but less than that of Molecule_1 and Molecule_3', 'Moderate free radical scavenging activity against DPPH as well as antioxidant activity, similar to Molecule_1', 'Free radical scavenging activity, lower than Molecule_1 and Molecule_3', 'Free radical scavenging activity, similar to that of Molecule_2 and Molecule_6', 'Free radical scavenging activity, similar to that of Molecule_2 and Molecule_5']]",doi_bioActivity
"['10.1021/np0303963', 'Cytotoxic']","['10.1021/np0303963', ['DNA-damaging activity on mutant yeast strains of Saccharomyces cerevisiae', 'Inactive on DNA-damaging activity assay', 'Inactive on DNA-damaging activity assay', 'DNA-damaging activity on mutant yeast strains of Saccharomyces cerevisiae']]",doi_bioActivity
"['10.1021/np030530j', 'Antifungal']","['10.1021/np030530j', ['Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum with high potential as antifungal compounds', 'Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum', 'Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum', 'Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum']]",doi_bioActivity
"['10.1021/np070312g', 'Antioxidant']","['10.1021/np070312g', ['Moderate antioxidant activities (40–70% at 100 ppm), moderate inhibition of COX-1 (ca. 40%) and marginal inhibition of COX-2 enzymes (<10% at 100 ppm)', 'Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 40% respectively at 100 ppm)', 'Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 58% respectively at 100 ppm)']]",doi_bioActivity
"['10.1021/np070312g', 'Anti-inflamatory']","['10.1021/np070312g', ['Moderate antioxidant activities (40–70% at 100 ppm), moderate inhibition of COX-1 (ca. 40%) and marginal inhibition of COX-2 enzymes (<10% at 100 ppm)', 'Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 40% respectively at 100 ppm)', 'Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 58% respectively at 100 ppm)']]",doi_bioActivity
"['10.1021/np100840w', 'Cytotoxic']","['10.1021/np100840w', ['Cytotoxicity against human melanoma (MDA/MB-435) and human glioblastoma (SF-295) cells with IC50 values of 0.36 μM', 'Cytotoxicity against human cancer cell lines with less potency compared to Molecule_1', 'Cytotoxicity not significant; IC50 values >5 μM', 'Cytotoxicity against human cancer cell lines with nearly similar potency to Molecule_1', 'Decreased cytotoxicity compared to non-acetylated molecules; IC50 values >5 μM', 'Decreased cytotoxicity compared to non-acetylated molecules; IC50 values >5 μM']]",doi_bioActivity
"['10.1021/np50086a012', 'Molluscicidal']","['10.1021/np50086a012', ['Moderate molluscicidal activity against the aquatic snail Biomphalaria glabrata with LC50 of 5 ppm; moderate cytotoxic activity against HeLa epithelioid carcinoma cells with IC50 of 2.5 µg/ml and against BT-20 human breast carcinoma cells', 'Moderate molluscicidal activity against the aquatic snail Biomphalaria glabrata with LC50 of 20 ppm; moderate cytotoxic activity against HeLa epithelioid carcinoma cells with IC50 of 8.5 µg/ml and against BT-20 human breast carcinoma cells']]",doi_bioActivity
"['10.1021/np50086a012', 'Cytotoxic']","['10.1021/np50086a012', ['Moderate molluscicidal activity against the aquatic snail Biomphalaria glabrata with LC50 of 5 ppm; moderate cytotoxic activity against HeLa epithelioid carcinoma cells with IC50 of 2.5 µg/ml and against BT-20 human breast carcinoma cells', 'Moderate molluscicidal activity against the aquatic snail Biomphalaria glabrata with LC50 of 20 ppm; moderate cytotoxic activity against HeLa epithelioid carcinoma cells with IC50 of 8.5 µg/ml and against BT-20 human breast carcinoma cells']]",doi_bioActivity
"['10.1021/np800612x', 'Cytotoxic']","['10.1021/np800612x', ['Not specifically mentioned, inactive for tested cell lines at given concentrations', 'Cytotoxic activity against human cancer cell lines HL-60 (human myeloblastic leukemia) and SF-295 (human glioblastoma)', 'Not specifically mentioned, inactive for tested cell lines at given concentrations', 'Not specifically mentioned, inactive for tested cell lines at given concentrations', 'Precursor for the design of metformin and other biguanide-type hypoglycemic drugs, inactive for tested cell lines at given concentrations']]",doi_bioActivity
"['10.1021/np800612x', 'Inhibition of Glycosidase']","['10.1021/np800612x', ['Not specifically mentioned, inactive for tested cell lines at given concentrations', 'Cytotoxic activity against human cancer cell lines HL-60 (human myeloblastic leukemia) and SF-295 (human glioblastoma)', 'Not specifically mentioned, inactive for tested cell lines at given concentrations', 'Not specifically mentioned, inactive for tested cell lines at given concentrations', 'Precursor for the design of metformin and other biguanide-type hypoglycemic drugs, inactive for tested cell lines at given concentrations']]",doi_bioActivity
"['10.1021/np9004079', 'Cytotoxic']","['10.1021/np9004079', ['Cytotoxic activity against human tumor cell lines; however, IC50 values were >5 µM indicating low or no activity in the tests carried out.', ""Not explicitly tested in the provided document, but similar cytotoxicity could be inferred as it's structurally related to Molecule_1."", 'Significant cytotoxicity against four cancer cell lines (HL-60, HCT-8, MDA/MB-435, and SF-295), with IC50 values ranging from 0.13 to 1.0 µM', 'Significant cytotoxicity against human tumor cell lines as part of a mixture with Molecule_3, with similar IC50 values.', 'Cytotoxic activity against human tumor cell lines; however, IC50 values were >5 µM indicating low or no activity in the tests carried out.']]",doi_bioActivity
"['10.1055/s-0029-1185364', 'Antitrypanosomal']","['10.1055/s-0029-1185364', ['Trypanocidal activity with IC50 of 27.0 µM', 'Weak trypanocidal activity, IC50 of 678.2 µM', 'Weak trypanocidal activity, IC50 of 93.5 µM', 'Weak trypanocidal activity, IC50 of 289.1 µM', 'Weak trypanocidal activity, IC50 of 620.1 µM', 'Potent trypanocidal activity, IC50 of 3.1 µM', 'Trypanocidal activity, IC50 of 47.5 µM']]",doi_bioActivity
"['10.1080/14786410412331271979', 'Cytotoxic']","['10.1080/14786410412331271979', ['Cytotoxic activity against C6 (rat glioma) cell lines (IC50=3.2 mg/mL) and Hep-2 (larynx epidermoid carcinoma) cell lines (IC50=3.6 mg/mL)', 'Cytotoxic activity against C6 (IC50=4.9 mg/mL) and HeLa (human cervix carcinoma) cell lines (IC50=5.3 mg/mL)', 'Moderate cytotoxic activity against C6, Hep-2, and HeLa cell lines.']]",doi_bioActivity
"['10.1080/14786410903335232', 'Anticancer']","['10.1080/14786410903335232', ['Inhibition of TNF-α induced NF-κB activity; anti-microbial, antioxidant, and cytotoxic properties', 'Inhibition of TNF-α induced NF-κB activity; greater inhibitory activity than gallic acid', 'Inhibition of TNF-α induced NF-κB activity', 'Inhibition of TNF-α induced NF-κB activity', 'Inhibition of TNF-α induced NF-κB activity', 'Inhibition of TNF-α induced NF-κB activity; most cytotoxic compound evaluated', 'Inhibition of TNF-α induced NF-κB activity', 'Inhibition of TNF-α induced NF-κB activity', 'Inhibition of TNF-α induced NF-κB activity']]",doi_bioActivity
"['10.1080/14786419.2011.647020', 'Antiallergenic']","['10.1080/14786419.2011.647020', ['anti-allergic activity']]",doi_bioActivity
"['10.1093/mutage/gep034', 'Cytotoxic']","['10.1093/mutage/gep034', ['Genotoxic and mutagenic at highest concentration; chemoprotective at low concentrations', 'Presence suggested, not clearly described']]",doi_bioActivity
"['10.1093/mutage/gep034', 'Genotoxic']","['10.1093/mutage/gep034', ['Genotoxic and mutagenic at highest concentration; chemoprotective at low concentrations', 'Presence suggested, not clearly described']]",doi_bioActivity
"['10.1093/mutage/gep034', 'Mutagenic']","['10.1093/mutage/gep034', ['Genotoxic and mutagenic at highest concentration; chemoprotective at low concentrations', 'Presence suggested, not clearly described']]",doi_bioActivity
"['10.1107/S1600536803019913', 'Antileishmanial']","['10.1107/S1600536803019913', ['Inhibitor of adenine phosphoribosyltransferase (APRT) enzyme from Leishmania']]",doi_bioActivity
"['10.1107/S160053680302107X', 'Antileishmanial']","['10.1107/S160053680302107X', ['Inhibition of adenine phosphoribosyltransferase (APRT) enzyme activity from Leishmania tarentolae']]",doi_bioActivity
"['10.1248/cpb.56.407', 'Anti-inflamatory']","['10.1248/cpb.56.407', ['Antinociceptive, semi-synthetic piperidine alkaloid derivatives showing central analgesic activity.', 'Significant antinociceptive activity by inhibiting acetic acid-induced abdominal constrictions with 37% of inhibition, no activity shown in the carrageenan-induced rat paw edema test for anti-inflammatory activity at the dose used.', 'Antinociceptive and anti-inflammatory, inhibited carrageenan-induced rat paw edema with an ED50 value of 56.6 mmol/kg, also acted as a peripheral analgesic.', 'Significant antinociceptive activity, notably in the formalin-induced pain test during the inflammatory phase, suggesting central analgesic activity without anti-inflammatory effects at the tested dose.', 'Series of 2,3,6-trisubstituted piperidine alkaloids showing varying levels of antinociceptive activity.']]",doi_bioActivity
"['10.1248/cpb.56.407', 'Antinociceptive']","['10.1248/cpb.56.407', ['Antinociceptive, semi-synthetic piperidine alkaloid derivatives showing central analgesic activity.', 'Significant antinociceptive activity by inhibiting acetic acid-induced abdominal constrictions with 37% of inhibition, no activity shown in the carrageenan-induced rat paw edema test for anti-inflammatory activity at the dose used.', 'Antinociceptive and anti-inflammatory, inhibited carrageenan-induced rat paw edema with an ED50 value of 56.6 mmol/kg, also acted as a peripheral analgesic.', 'Significant antinociceptive activity, notably in the formalin-induced pain test during the inflammatory phase, suggesting central analgesic activity without anti-inflammatory effects at the tested dose.', 'Series of 2,3,6-trisubstituted piperidine alkaloids showing varying levels of antinociceptive activity.']]",doi_bioActivity
"['10.1515/znc-2008-5-611', 'Antileishmanial']","['10.1515/znc-2008-5-611', ['Inhibition of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH)', 'Inhibition of gGAPDH and trypanocidal activity', 'Limited trypanocidal activity; not tested for enzyme inhibition', 'Not established in this document', 'Not tested for enzyme inhibition or trypanocidal activity', 'Not tested for enzyme inhibition or trypanocidal activity', 'Limited trypanocidal activity; not tested for enzyme inhibition', 'Inhibition of APRT', 'Trypanocidal activity against T. cruzi', 'Inhibition of T. cruzi trypomastigote lysis', 'Inhibition of TR and strong inhibitory activity on gGAPDH', 'Inhibition of TR and strong inhibitory activity on gGAPDH', 'Not tested for enzyme inhibition or trypanocidal activity', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH, APRT, and trypanocidal activity', 'Inhibition of gGAPDH and APRT', 'Limited trypanocidal activity; not tested for enzyme inhibition', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Not tested for enzyme inhibition or trypanocidal activity']]",doi_bioActivity
"['10.1515/znc-2008-5-611', 'Antitrypanosomal']","['10.1515/znc-2008-5-611', ['Inhibition of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH)', 'Inhibition of gGAPDH and trypanocidal activity', 'Limited trypanocidal activity; not tested for enzyme inhibition', 'Not established in this document', 'Not tested for enzyme inhibition or trypanocidal activity', 'Not tested for enzyme inhibition or trypanocidal activity', 'Limited trypanocidal activity; not tested for enzyme inhibition', 'Inhibition of APRT', 'Trypanocidal activity against T. cruzi', 'Inhibition of T. cruzi trypomastigote lysis', 'Inhibition of TR and strong inhibitory activity on gGAPDH', 'Inhibition of TR and strong inhibitory activity on gGAPDH', 'Not tested for enzyme inhibition or trypanocidal activity', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH, APRT, and trypanocidal activity', 'Inhibition of gGAPDH and APRT', 'Limited trypanocidal activity; not tested for enzyme inhibition', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH', 'Inhibition of gGAPDH and APRT', 'Inhibition of gGAPDH and APRT', 'Not tested for enzyme inhibition or trypanocidal activity']]",doi_bioActivity
"['10.1590/S0073-47212009000100009', 'Insecticidal']","['10.1590/S0073-47212009000100009', ['Toxicity; Ingestion and topical application tests showed significant mortality rates in worker bees and larvae of Apis mellifera and Scaptotrigona postica, with observable symptoms of intoxication such as sluggish movement, disorientation, leg trembling, paralysis, and eventual death.']]",doi_bioActivity
"['10.1590/S0100-40422005000400009', 'Antifungal']","['10.1590/S0100-40422005000400009', ['Antifungal activity (moderate activity against Cladosporium cladosporioides)', 'Antifungal activity (moderate activity against Cladosporium cladosporioides; New compound, not previously described in literature)', 'Antifungal activity (no activity alone but mixture with Molecule 4 shows activity)', 'Antifungal activity (part of the activity attributed to mixture with Molecule 3 against Cladosporium cladosporioides)', 'Antifungal activity not tested']]",doi_bioActivity
"['10.1590/S0100-40422005000600011', 'Antifungal']","['10.1590/S0100-40422005000600011', ['Active against Cladosporium cladosporioides and Cladosporium sphaerospermum (antifungal)', 'Active against Cladosporium cladosporioides and Cladosporium sphaerospermum (antifungal)', 'Known as a powerful antifungal agent used commercially, but no antifungal activity reported in this specific test against Cladosporium cladosporioides and Cladosporium sphaerospermum']]",doi_bioActivity
"['10.1590/S0100-40422008000400005', 'Antitrypanosomal']","['10.1590/S0100-40422008000400005', ['Moderate Trypanocidal Activity (IC50 136.9 µM)', 'Moderate Trypanocidal Activity (IC50 144.9 µM)']]",doi_bioActivity
"['10.1590/S0100-40422008000400023', 'Antifungal']","['10.1590/S0100-40422008000400023', ['Moderate antifungal activity (MIC 100.0 µg/mL)', 'Moderate antifungal activity (MIC 100.0 µg/mL)', 'Weak antifungal activity (MIC 200.0 µg/mL)', 'Inactive']]",doi_bioActivity
"['10.1590/S0100-40422010000900005', 'Insecticidal']","['10.1590/S0100-40422010000900005', ['Insecticidal activity against Spodoptera frugiperda']]",doi_bioActivity
"['10.1590/S0102-695X2007000300003', 'Antioxidant']","['10.1590/S0102-695X2007000300003', ['Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Weak scavenging activity with IC50 of 50.0 µM against DPPH free radical.', 'Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Weak scavenging activity with IC50 of 40.7 µM against DPPH free radical.', 'Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Weak scavenging activity with IC50 of 35.4 µM against DPPH free radical.', 'Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Moderate scavenging activity with IC50 of 18.5 µM against DPPH free radical.']]",doi_bioActivity
"['10.1590/S0102-695X2009000100002', 'Antitrypanosomal']","['10.1590/S0102-695X2009000100002', ['Low inhibitory activity against T. cruzi gGAPDH enzyme', 'High inhibitory activity against T. cruzi gGAPDH enzyme', 'Complete inhibition of T. cruzi gGAPDH enzyme at 268.8 mmol/L']]",doi_bioActivity
"['10.1590/S0102-695X2012005000106', 'Cytotoxic']","['10.1590/S0102-695X2012005000106', ['Cytotoxic activity against human cancer cell lines; selective cytotoxicity against oral carcinoma and breast cancer cell lines', 'Cytotoxic activity against different cancer cell lines; Leishmanicidal activity against Leishmania braziliensis; Reported activity against other cancer lines, HIV1 virus, and bacterial strains']]",doi_bioActivity
"['10.1590/S0102-695X2012005000106', 'Antileishmanial']","['10.1590/S0102-695X2012005000106', ['Cytotoxic activity against human cancer cell lines; selective cytotoxicity against oral carcinoma and breast cancer cell lines', 'Cytotoxic activity against different cancer cell lines; Leishmanicidal activity against Leishmania braziliensis; Reported activity against other cancer lines, HIV1 virus, and bacterial strains']]",doi_bioActivity
"['10.1590/S0103-50532005000300018', 'Inhibition of Acetylcholinesterase']","['10.1590/S0103-50532005000300018', ['Moderate trypanocidal activity', 'Moderate trypanocidal activity']]",doi_bioActivity
"['10.1590/S0103-50532005000400005', 'Antioxidant']","['10.1590/S0103-50532005000400005', ['Poor radical scavenger due to absence of phenolic hydroxyls', 'Poor radical scavenger', 'Poor radical scavenger', 'Free radical scavenger (ΔA 32% at 50 µmol L-1)', 'Strong radical scavenger (ΔA 73% at 50 µmol L-1)', 'Free radical scavenger (ΔA 16% at 50 µmol L-1)']]",doi_bioActivity
"['10.1590/S0103-50532005000800008', 'Antioxidant']","['10.1590/S0103-50532005000800008', ['Strong antioxidative properties', 'Strong antioxidant activity', 'Antioxidant activity', 'Antioxidant activity', 'Strong antioxidant activity', 'Strong antioxidant activity', 'Antioxidant activity', 'Antioxidant activity', 'Antioxidant activity', 'Strong antioxidant activity', 'Very strong antioxidant activity']]",doi_bioActivity
"['10.1590/S0103-50532005000800026', 'Inhibition of Acetylcholinesterase']","['10.1590/S0103-50532005000800026', ['insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration', 'insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration', 'insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration', 'insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration', 'insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration', 'insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration', 'insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration']]",doi_bioActivity
"['10.1590/S0103-50532006000300017', 'Insecticidal']","['10.1590/S0103-50532006000300017', ['Moderate insecticidal activities against Atta sexdens rubropilosa workers', 'Moderate insecticidal activities against Atta sexdens rubropilosa workers', 'Moderate insecticidal activities against Atta sexdens rubropilosa workers', 'Moderate insecticidal activities against Atta sexdens rubropilosa workers', 'Moderate insecticidal activities against Atta sexdens rubropilosa workers']]",doi_bioActivity
"['10.1590/S0103-50532009000400008', 'Antitrypanosomal']","['10.1590/S0103-50532009000400008', [{'P_falciparum': 'IC50 2.6 ± 0.4 µM', 'T_b_rhodesiense': 'IC50 9.6 ± 1.1 µM', 'L_donovani': 'Inactive', 'KB_cells': 'IC50 19.8 ± 3.7 µM'}, {'P_falciparum': 'IC50 3.0 ± 0.2 µM', 'T_b_rhodesiense': 'IC50 4.3 ± 0.9 µM', 'L_donovani': 'Inactive', 'KB_cells': 'IC50 > 100 µM'}, {'P_falciparum': 'IC50 11.6 ± 1.2 µM', 'T_b_rhodesiense': 'IC50 28.5 ± 2.9 µM', 'L_donovani': 'Inactive', 'KB_cells': 'IC50 80.7 ± 6.8 µM'}]]",doi_bioActivity
"['10.1590/S0103-50532010000500016', 'Insecticidal']","['10.1590/S0103-50532010000500016', ['Insecticidal and Fungicidal', 'Insecticidal and Fungicidal, weak activity in ants ingestion assay', 'Insecticidal and Fungicidal, though not toxic to the leaf-cutting ants', 'Toxicity against leaf-cutting ants', 'Potentially active compound against A. sexdens rubropilosa, significant ant mortality', 'Toxicity against leaf-cutting ants']]",doi_bioActivity
"['10.1590/S1519-566X2008000600013', 'Insecticidal']","['10.1590/S1519-566X2008000600013', ['Increase in larval mortality, elongation of larval development time, and reduction in larval survival', 'Less effective than other compounds against T. absoluta', 'Less effective than other compounds against T. absoluta', 'Among the most effective against T. absoluta, causing prolongation of larval development and reduction in larval survival', 'Less effective than other compounds against T. absoluta', 'Less effective than other compounds against T. absoluta', 'Among the most effective against T. absoluta, causing prolongation of larval development and reduction in larval survival']]",doi_bioActivity
"['10.1590/s0100-40422008000700015', 'Cytotoxic']","['10.1590/s0100-40422008000700015', ['Inhibition of 89.55% against Jurkat (leukemia) and 57.10% against B16F10 (melanoma) tumoral cells at 0.1 mg mL-1 concentration, weak antibacterial activity against Staphylococcus aureus (MIC 120 µg/mL) and Escherichia coli (MIC 189 µg/mL)', 'Not specifically mentioned, but chemically similar to Chaetoglobosin B which is typically cytotoxic', 'Not specifically mentioned, but chemically similar to Chaetoglobosin B which is typically cytotoxic']]",doi_bioActivity
"['10.3390/molecules15129205', 'Inhibition of Acetylcholinesterase']","['10.3390/molecules15129205', ['Acetylcholinesterase inhibition with IC50 value of 0.21 mM', 'Acetylcholinesterase inhibition with IC50 value of 2.5 μM, similar to reference compound galanthamine', 'Acetylcholinesterase inhibition with IC50 value of 46 μM', 'Acetylcholinesterase inhibition with IC50 value of 1.4 mM', 'Acetylcholinesterase inhibition, specific activity not reported', 'Acetylcholinesterase inhibition, specific activity not reported']]",doi_bioActivity
"['10.3390/molecules190812031', 'Antileishmanial']","['10.3390/molecules190812031', ['Possible artefact from isolation procedures']]",doi_bioActivity
"['10.4067/S0717-97072009000300004', 'Inhibition of Glycosidase']","['10.4067/S0717-97072009000300004', []]",doi_bioActivity
"['10.5935/0100-4042.20140049', 'Cytotoxic']","['10.5935/0100-4042.20140049', ['Moderate inhibitory activity against cathepsin B with an IC50 of 62.02 µM', 'Significant toxicity against CNS cancer cell line (SF-295) with IC50 = 36.80 µM and human leukemia (HL-60) with IC50 = 25.37 µM']]",doi_bioActivity
"['10.5935/0103-5053.19930018', 'Antitrypanosomal']","['10.5935/0103-5053.19930018', []]",doi_bioActivity
